Oncolytic herpes simplex virus vectors for the treatment of human breast cancer

Chinese Medical Journal

Volumn 118, Issue 4, 2005, Pages 307-312

  Liu, Ren Bin ^a   Rabkin, Samuel D ^b,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Cancer therapy; Gene therapy; Herpes simplex virus; Oncolytic virus

Indexed keywords

ONCOLYTIC VIRUS; VIRUS ONCOLYSATE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TUMOR GROWTH; VIRUS REPLICATION;

ANIMALS; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; SIMPLEXVIRUS; TRANSPLANTATION, HETEROLOGOUS; VIRUS REPLICATION;

EID: 14644435811     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64.
2. Shu XO, Jin F, Dai Q, et al. Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer 2001;94:449-455.
3. Jin F, Devesa SS, Chow WH, et al. Cancer incidence trends in urban shanghai, 1972-1994: an update. Int J Cancer 1999;83:435-440.
4. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
5. Howe HL, Wingo PA, Thun MJ, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001;93:824-842.
6. Kirn D, Martuza RL, Zwiebel J. Replication-selective virotherapy for cancer: Biological principles, risk management and future directions. Nat Med 2001;7: 781-787.
7. Varghese S, Rabkin SD. Oncolytic herpes simplex virus vectors for cancer virotherapy. Cancer Gene Ther 2002;9:967-978.
8. Rabkin SD, Hernaiz-Driever P. Replication-competent herpes simplex virus vectors for cancer therapy. In: Rabkin SO, Hernaiz Driever P, eds. Replication-competent viruses for cancer therapy. Basel: S. Karger AG; 2001:1-45.
9. Cozzi PJ, Malhotra S, McAuliffe P, et al. Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model. FASEB J 2001;15:1306-1308.
10. Delman KA, Bennett JJ, Zager JS, et al. Effects of preexisting immunity on the response to herpes simplex-based oncolytic viral therapy. Hum Gene Ther 2000; 11:2465-2472.
11. Bennett JJ, Delman KA, Burt BM, et al. Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer. Cancer Gene Ther 2002;9:935-945.
12. Cozzi PJ, Burke PB, Bhargav A, et al. Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses. Prostate 2002;53:95-100.
13. Todo T, Martuza RL, Rabkin SD, et al. Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing. Proc Natl Acad Sci U S A 2001;98:6396-6401.
14. Wong RJ, Patel SG, Kim S, et al. Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma. Hum Gene Ther 2001; 12: 253-265.
15. Cailleau R, Olive M, Crucigar QV. Long term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 1978; 14: 911-915.
16. Horwitz KB, Zava DT, Thilagar AK, et al. Steroid receptor analyses of nine human breast cancer cell lines. Cancer Res 1978;38:2434-2437.
17. Kirn D, Niculescu-Duvaz I. Hallden G, et al. The emerging fields of suicide gene therapy and virotherapy. Trends Mol Med 2002;8:S68-S73.
18. Mohr I, Gluzman Y. A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function. EMBO J 1996;15:4759-4766.
19. Roizman B. The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors. Proc Natl Acad Sci U S A 1996;93:11307-11312.
20. Wong RJ, Joe JK, Kim SH, et al. Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases. Hum Gene Ther 2002; 13:1213-1223.